TP53 and neoplasm: Taken together, these results showed that MDM2 inhibitor RG7388 exerts an anti‐tumour effect via induction of both apoptosis and cell cycle arrest and these findings are in line with the dual role of P53 partaking in both apoptosis and G1‐phase checkpoint pathway.